SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-106980
Filing Date
2024-04-23
Accepted
2024-04-23 16:06:58
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-23

Document Format Files

Seq Description Document Type Size
1 ARS d296519dars.pdf ARS 3033270
  Complete submission text file 0001193125-24-106980.txt   4177985
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-35890 | Film No.: 24864868
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)